tiprankstipranks
Trending News
More News >
Sana Biotechnology (SANA)
NASDAQ:SANA
US Market

Sana Biotechnology (SANA) Income Statement

Compare
822 Followers

Sana Biotechnology Income Statement

Last quarter (Q3 2025), Sana Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sana Biotechnology's net income was $-42.15M. See Sana Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -10.17M
Operating Expenses
$ 272.72M$ 293.14M$ 272.56M$ 356.91M$ 150.95M
Depreciation and Amortization
$ 17.39M$ 24.56M$ 15.63M$ 11.07M$ 10.17M
EBITDA
$ -255.33M$ -268.58M$ -256.94M$ -345.84M$ -287.03M
Operating Income
$ -272.72M$ -293.14M$ -272.56M$ -356.91M$ -161.12M
Other Income/Expenses
$ 5.96M$ 9.89M$ 3.09M$ 981.00K$ -136.08M
Pretax Income
$ -266.76M$ -283.25M$ -269.48M$ -355.93M$ -297.20M
Net Income
$ -266.76M$ -283.25M$ -269.48M$ -355.93M$ -285.31M
Per Share Metrics
Basic EPS
$ -1.16$ -1.46$ -1.43$ -2.14$ -1.63
Diluted EPS
$ -1.16$ -1.46$ -1.43$ -2.14$ -1.63
Weighted Average Shares Outstanding
230.89M 194.54M 188.34M 166.43M 187.51M
Weighted Average Shares Outstanding (Diluted)
230.89M 194.54M 188.34M 166.43M 187.51M
Currency in USD

Sana Biotechnology Earnings and Revenue History